DZ Bank
RARE icon

DZ Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

DZ Bank’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,339
Closed -$1.55M – 1051
2025
Q4 		$1.55M Sell
67,339
-213,127
-76% -$7.01M ﹤0.01% 658
2025
Q3 		$8.44M Sell
280,466
-30,635
-10% -$919K 0.01% 414
2025
Q2 		$11.3M Hold
311,101
– – 0.01% 357
2025
Q1 		$11.3M Sell
311,101
-35,496
-10% -$1.48M 0.01% 335
2024
Q4 		$14.6M Buy
346,597
+51,874
+18% +$2.57M 0.01% 282
2024
Q3 		$16.4M Hold
294,723
– – 0.02% 292
2024
Q2 		$12.1M Buy
294,723
+137,447
+87% +$5.87M 0.01% 317
2024
Q1 		$7.34M Buy
+157,276
New +$7.42M 0.01% 407
2018
Q2 		– Sell
-23,909
Closed -$1.22M – 1038
2018
Q1 		$1.22M Buy
+23,909
New +$1.2M ﹤0.01% 620

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return